Topics |
Speakers |
Time |
Venue |
A-V ACCESS FOR HAEMODYALISIS
|
|
08.00-09.09 |
Session 16 |
Clinical evidence on management of clotted haemodialysis access: VITAE registry
|
|
8.01 |
|
Vascular access for haemodialysis
|
|
8.07 |
|
Optimizing functional patency in AVG: what treatment and when
|
|
8.13 |
|
External support device for AVF: the next standard of care? An all clinical data update
|
|
8.19 |
|
ESVS clinical practice guidelines
|
|
8.25 |
|
AVF creation: comparing surgical and percutaneous outcomes
|
|
8.31 |
|
Will endoAVF ever become the gold standard? Surgery is still the gold standard
|
|
8.37 |
|
Is there any current role for DCB and DES?
|
|
8.43 |
|
How to avoid and how to manage haemodialysis access failure: tips and tricks
|
|
8.49 |
|
How does endoAVF fit into patient's life plan: not only creating an AV fistula but also making a difference
|
|
8.55 |
|
Round table/Discussion
|
|
9.01-9.09 |
|
MISCELLANEA | PERIPHERAL DISEASE
|
|
09.10-10.09 |
Session 17 |
15 years preserving hypogastric arteries - Results from pELVIS registry
|
|
9.11 |
|
What is a good vein? Heparin Bonded Grafts vs Vein for BTK by-pass in CLTI: when to use what?
|
|
9.17 |
|
Superior mesenteric artery syndrome and treatment
|
|
9.23 |
|
How do I find my way to the true lumen and when do I stent visceral branches?
|
|
9.29 |
|
Drug eluting stent: superior primary patency in the treatment of PAD
|
|
9.35 |
|
Modern approach for long SFA occlusion
|
|
9.41 |
|
Distal bypass surgery: how to achieve life long success? How do I do it
|
|
9.47 |
|
Visceral artery aneurysms – Experience with more than 230 cases
|
|
9.53 |
|
Round table/Discussion
|
|
09.59-10.09 |
|
AORTIC DISEASE
|
|
10.10-11.04 |
Session 18 |
Long term results of Ilac branch endografts
|
|
10.11 |
|
Initial experience in endovascular treatment of aortic arch aneurysm
|
|
10.17 |
|
Curvature remodelling after TEVAR
|
|
10.23 |
|
Outcomes of upper vs lower extremity access for F/BEVAR
|
|
10.29 |
|
Reconsidering aortic sealing in a dynamic environment
|
|
10.35 |
|
Off the shelf modified TEVAR solution: single center experience
|
|
10.41 |
|
How to employ routinely vessel closure device during complex endovascular aortic procedures
|
|
10.47 |
|
Lessons learned in the treatment of uncommon visceral arteries
|
|
10.53 |
|
Round table/Discussion
|
|
10.59-11.04 |
|
MISCELLANEA
|
|
11.05-12.04 |
Session 19 |
Technical tips to perform safe large percutaneous femoral access for complex AAA EVAR in obese or scarred groins; results from trans-atlantic collaboration
|
|
11.06 |
|
Post coarctation aneurysms: results of an international registry
|
|
11.12 |
|
Custom made solution with inner branch technology: technical issues and results of Celer Study
|
|
11.18 |
|
ESAR can improve EVAR outcomes in hostile sealing zones: insights from ANCHOR registry
|
|
11.24 |
|
Midaortic syndrome and renovascular disease in pediatric population: decision making & surgical strategy
|
|
11.30 |
|
Update on different types of inner branch endografts
|
|
11.36 |
|
How does the NICE guidelines will affect the practice in Egypt?
|
|
11.42 |
|
Inverted T bypass: pushing the limits of distal and ultra distal CLTI
|
|
11.48 |
|
Round table/Discussion
|
|
11.54-12.04 |
|
KEYNOTE LECTURE VIII
|
|
12.05-12.19 |
|
INFECTIONS/ENDOLEAKS
|
|
12.20-13.24 |
Session 20 |
Bovine pericardial tube graft for aortic replacement in infected bed
|
|
12.21 |
|
Xenopericardial grafts for native and graft-related aortic infections
|
|
12.27 |
|
Graft infection European guidelines
|
|
12.33 |
|
Surgical treatment of native and prosthetic aortic infection with xenopericardial tube-grafts from the ascending aorta beyond the bifurcation
|
|
12.39 |
|
The treatment of aortic prosthetic infection with homograft
|
|
12.45 |
|
Management of aortic graft infections – results from a large nationwide study
|
|
12.51 |
|
Mycotic aortic aneurysms: open vs endovascular or can we have the best of both worlds?
|
|
12.57 |
|
Treatment of refractory Type II EL: from embolization to conversion
|
|
13.03 |
|
Transcaval embolisation for endoleak Type II
|
|
13.09 |
|
Round table/Discussion
|
|
13.15-13.24 |
|
WINNER OF THE YOUNG INVESTIGATORS COMPETITION
|
|
13.25-13.30 |
|